Cell Cycle Proteins

"Cell Cycle Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.

Descriptor ID	D018797
MeSH Number(s)	D12.776.167
Concept/Terms	Cell Cycle Proteins Cell Cycle Proteins Cell Division Cycle Proteins Cell-Cycle Regulatory Proteins Cell Cycle Regulatory Proteins cdc Proteins

Below are MeSH descriptors whose meaning is more general than "Cell Cycle Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Cell Cycle Proteins [D12.776.167]

Below are MeSH descriptors whose meaning is related to "Cell Cycle Proteins".

Below are MeSH descriptors whose meaning is more specific than "Cell Cycle Proteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cell Cycle Proteins" by people in this website by year, and whether "Cell Cycle Proteins" was a major or minor topic of these publications.

Bar chart showing 1205 publications over 31 distinct years, with a maximum of 85 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1990	1	0	1
1991	4	0	4
1992	6	0	6
1993	9	0	9
1994	13	1	14
1995	13	2	15
1996	14	4	18
1997	20	7	27
1998	30	8	38
1999	35	11	46
2000	31	8	39
2001	41	16	57
2002	32	27	59
2003	39	29	68
2004	37	48	85
2005	46	36	82
2006	29	19	48
2007	26	20	46
2008	43	19	62
2009	23	26	49
2010	25	30	55
2011	29	32	61
2012	31	23	54
2013	16	14	30
2014	12	24	36
2015	16	23	39
2016	17	18	35
2017	22	16	38
2018	17	15	32
2019	22	14	36
2020	9	7	16

Below are the most recent publications written about "Cell Cycle Proteins" by people in Profiles.

Chakravarti D, Hu B, Mao X, Rashid A, Li J, Li J, Liao WT, Whitley EM, Dey P, Hou P, LaBella KA, Chang A, Wang G, Spring DJ, Deng P, Zhao D, Liang X, Lan Z, Lin Y, Sarkar S, Terranova C, Deribe YL, Blutt SE, Okhuysen P, Zhang J, Vilar E, Nielsen OH, Dupont A, Younes M, Patel KR, Shroyer NF, Rai K, Estes MK, Wang YA, Bertuch AA, DePinho RA. Telomere dysfunction activates YAP1 to drive tissue inflammation. Nat Commun. 2020 09 21; 11(1):4766.

View in: PubMed
Wen Y, Wang Y, Chelariu-Raicu A, Stur E, Liu Y, Corvigno S, Bartsch F, Redfern L, Zand B, Kang Y, Liu J, Baggerly K, Sood AK. Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer. Mol Cancer Ther. 2020 09; 19(9):1943-1954.

View in: PubMed
Cheng H, Zhang N, Pati D. Cohesin subunit RAD21: From biology to disease. Gene. 2020 Oct 20; 758:144966.

View in: PubMed
Gnedeva K, Wang X, McGovern MM, Barton M, Tao L, Trecek T, Monroe TO, Llamas J, Makmura W, Martin JF, Groves AK, Warchol M, Segil N. Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal. Proc Natl Acad Sci U S A. 2020 06 16; 117(24):13552-13561.

View in: PubMed
Wu SY, Lee CF, Lai HT, Yu CT, Lee JE, Zuo H, Tsai SY, Tsai MJ, Ge K, Wan Y, Chiang CM. Opposing Functions of BRD4 Isoforms in Breast Cancer. Mol Cell. 2020 06 18; 78(6):1114-1132.e10.

View in: PubMed
Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanovic B, Murphy K, Wang B, Qiu X, Endress JE, Reyes J, Lim K, Font-Tello A, Syamala S, Xiao T, Reddy Chilamakuri CS, Papachristou EK, D'Santos C, Anand J, Hinohara K, Li W, McDonald TO, Luoma A, Modiste RJ, Nguyen QD, Michel B, Cejas P, Kadoch C, Jaffe JD, Wucherpfennig KW, Qi J, Liu XS, Long H, Brown M, Carroll JS, Brugge JS, Bradner J, Michor F, Polyak K. Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Mol Cell. 2020 06 18; 78(6):1096-1113.e8.

View in: PubMed
Rao L, Mak VCY, Zhou Y, Zhang D, Li X, Fung CCY, Sharma R, Gu C, Lu Y, Tipoe GL, Cheung ANY, Mills GB, Cheung LWT. p85ß regulates autophagic degradation of AXL to activate oncogenic signaling. Nat Commun. 2020 05 08; 11(1):2291.

View in: PubMed
Saenz DT, Fiskus W, Mill CP, Perera D, Manshouri T, Lara BH, Karkhanis V, Sharma S, Horrigan SK, Bose P, Kadia TM, Masarova L, DiNardo CD, Borthakur G, Khoury JD, Takahashi K, Bhaskara S, Lin CY, Green MR, Coarfa C, Crews CM, Verstovsek S, Bhalla KN. Mechanistic basis and efficacy of targeting the ß-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors. Blood. 2020 04 09; 135(15):1255-1269.

View in: PubMed
Zhang Y, Shi J, Liu X, Xiao Z, Lei G, Lee H, Koppula P, Cheng W, Mao C, Zhuang L, Ma L, Li W, Gan B. H2A Monoubiquitination Links Glucose Availability to Epigenetic Regulation of the Endoplasmic Reticulum Stress Response and Cancer Cell Death. Cancer Res. 2020 06 01; 80(11):2243-2256.

View in: PubMed
Liu K, Graves JD, Lee YJ, Lin FT, Lin WC. Cell Cycle-Dependent Switch of TopBP1 Functions by Cdk2 and Akt. Mol Cell Biol. 2020 03 30; 40(8).

View in: PubMed

People

Explore

Similar Concepts

Top Journals